Drug Type Small molecule drug |
Synonyms Gemcitabine 5'-elaidic acid ester, Gemcitabine elaidate (USAN/INN), CO-1.01 + [2] |
Target- |
Action inhibitors |
Mechanism DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H43F2N3O5 |
InChIKeyHESSNRGIEVBPRB-QDDPNBLJSA-N |
CAS Registry210829-30-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic adenocarcinoma metastatic | Phase 2 | United States | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Argentina | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Australia | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Belgium | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Brazil | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Canada | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | France | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Germany | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Italy | 01 May 2010 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | Netherlands | 01 May 2010 |
Phase 2 | 367 | (CO-1.01) | bowqawezcu(uuylzpxzcx) = pqlfmoespl yonlwbikli (eenntabigl, dokodsxqdh - sdyjzrtcsm) View more | - | 17 Apr 2014 | ||
(Gemcitabine) | bowqawezcu(uuylzpxzcx) = ajujpuojow yonlwbikli (eenntabigl, tdbzysvjfo - fxeauladkt) View more | ||||||
Phase 2 | 367 | lzfgykewyh(xbtjxrnora): HR = 0.994 (95% CI, 0.746 - 1.326) | Negative | 20 May 2013 | |||
Gemcitabine | |||||||
Phase 2 | - | mvlzmselcf(qucgazttyk) = ikvgtczpdc siumqxaffv (hjfazwpvrs ) | - | 20 May 2010 | |||
mvlzmselcf(qucgazttyk) = afwhkzgvge siumqxaffv (hjfazwpvrs ) |